I Had Lung Cancer 3 Times. This Is What A Week Of Chemotherapy Was Like For Me
5/17/2017 Christy Fischer was just 38 when she was first diagnosed with stage-IV lung cancer. After chemotherapy helped her defeat the disease, her cancer returned twice.
AstraZeneca's shares spike on a surprise coup in PhIII lung cancer data
5/17/2017 AstraZeneca $AZN shares popped more than 7% this morning on positive Phase III progression-free survival data for Imfinzi (durvalumab) in treating advanced, inoperable and chemo-resistant non-small cell lung cancer. Analysts did a quick double take and ...
Brigatinib first to offer over 1-year control of ALK-positive lung cancer post-crizotinib
5/17/2017 However, two major problems have remained: Crizotinib does not pass into the brain and so is unable to target ALK-positive lung cancer in the central nervous system, and the genetic diversity of cancer allows the later growth of subpopulations that can ...
Lung cancer workshop set May 30
5/17/2017 Gilda's Club Quad-Cities, 1234 E. River Drive, Davenport, will host Frankly Speaking About Cancer: Lung Cancer workshop for people affected by lung cancer. Dr. Costas L. Constantinou of Hematology and Oncology Care - Iowa will present the free ...
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer
5/17/2017 The FDA has approved use of a Merck drug in combination with chemotherapy as a first-line treatment for the most common type of lung cancer. The FDA approval for (NYSE: MRK) pembrozlizumab (Keytruda) to treat metastatic nonsquamous non-small cell ...
AstraZeneca Has Opportunity In Lung Cancer Treatment Vs. Dow's Merck
5/17/2017 The suggestion followed strong results from AstraZeneca's drug Imfinzi in Stage 3 lung cancer patients, announced Friday.
Prototype drug uses novel mechanism to treat lung cancers
5/17/2017 Cells are constantly turning proteins on and off via molecular switches—phosphate molecules—that have become common drug targets.
Gefitinib delays recurrence in some patients with lung cancer
5/17/2017 Gefitinib significantly prolonged DFP compared with standard-of-care chemotherapy in patients with EGFR–positive stage II or IIIa non–small cell lung cancer, according to a phase 3 clinical trial scheduled for presentation at the ASCO Annual Meeting.
Woman delays lung cancer surgery to walk at UNLV graduation
5/17/2017 King, a lifelong nonsmoker who has stage 3 lung cancer, postponed her second surgery so she could walk in UNLV's spring commencement ceremony at the Thomas & Mack Center.
Lung Cancer Treatment Shows Promise With TG4010 and CIMAvax-EGF Vaccine Therapies
5/17/2017 In 2017, an estimated 222,500 Americans will be diagnosed with lung cancer - 13% of all newly diagnosed cancers. In the same year 155,870 Americans will die of the disease, accounting for about 26% of all cancer deaths overall, according to the ...